Stada and Xbrane receive approval for Ximluci
Biosimilar gains MHRA marketing authorisation for use throughout Britain - News - PharmaTimes
Source: pharmatimes.com
Stay updated with breaking news from Stada . Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Biosimilar gains MHRA marketing authorisation for use throughout Britain - News - PharmaTimes
Partnership combines Xbrane’s protein-expression system with Stada’s management teams - News - PharmaTimes
Company is introducing abiraterone film-coated tablets for treating metastatic prostate cancer - News - PharmaTimes